Koken Valuation
Is 7963 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 7963 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 7963 (¥1628) wird unter unserer Schätzung des Fair Value (¥1633.11) gehandelt.
Deutlich unter dem Marktwert: 7963 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7963?
Other financial metrics that can be useful for relative valuation.
What is 7963's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | JP¥7.97b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | 7.4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 7963's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 40.4x | ||
5187 Create Medic | 59.9x | n/a | JP¥9.2b |
7702 JMSLtd | 62.8x | n/a | JP¥13.0b |
3604 Kawamoto | 10.1x | n/a | JP¥4.7b |
7743 SEEDLtd | 28.9x | n/a | JP¥19.0b |
7963 Koken | 11.4x | n/a | JP¥8.0b |
Price-To-Earnings gegen Gleichaltrige: 7963 ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (10.6x) mit dem Durchschnitt der anderen Unternehmen (54.6x) vergleicht.
Price to Earnings Ratio vs Industry
How does 7963's PE Ratio compare vs other companies in the JP Medical Equipment Industry?
Price-To-Earnings gegen Industrie: 7963 ist aufgrund seines Price-To-Earnings Verhältnisses (10.6x) im Vergleich zum JP Medical Equipment Branchendurchschnitt (17.4x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 7963's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 11.4x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von 7963 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.